PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0022658|kidney disease |
| Sentences | 118 |
| PubMedID- 20401476 | When does the cardiovascular disease appear in patients with chronic kidney disease. |
| PubMedID- 25018979 | Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. |
| PubMedID- 23095239 | Cardiovascular disease is increased in patients with chronic kidney disease (ckd) and is the principle cause of morbidity and mortality in these patients. |
| PubMedID- 26102877 | Objective: increased risk of cardiovascular disease in patients with chronic kidney disease (ckd) has been related to vascular stiffness and isolated systolic hypertension as a result of vascular calcification due to mineral metabolism abnormalities. |
| PubMedID- 23389416 | Elevated fibroblast growth factor 23 (fgf23) is associated with cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 23573421 | Haptoglobin genotype and risk markers of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 23577141 | The cardiovascular disease burden in patients with chronic kidney disease (ckd) is substantial and derives from numerous aggregating cardiovascular risk factors [1]. |
| PubMedID- 23206977 | Accelerated atherosclerosis and arterial stiffness are the two leading causes of increased cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 24632542 | Coronary artery calcification and cardiovascular disease in children with chronic kidney disease. |
| PubMedID- 20829421 | Background and objectives: most deaths in autosomal dominant polycystic kidney disease (adpkd) are attributable to cardiovascular disease (cvd). |
| PubMedID- 26236158 | Anemia is an independent risk factor for development of cardiovascular diseases in patients with chronic kidney disease. |
| PubMedID- 24766515 | Similar results were obtained from further analyses including data adjusted for age, sex, dyslipidemia, diabetes, chronic kidney disease, history of cardiovascular disease, and changes in the number and dose of antihypertensive drugs (other than olmesartan) during the 16-week follow-up period. |
| PubMedID- 23740131 | Background: hyperphosphatemia is associated with cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 23474010 | Background: chronic kidney disease is associated with cardiovascular disease. |
| PubMedID- 20113258 | The importance of cardiovascular disease in adults with chronic kidney disease is now well recognized. |
| PubMedID- 20430946 | It is not known if p-cresol is associated with cardiovascular disease in patients with chronic kidney disease not yet on dialysis. |
| PubMedID- 21983848 | Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease. |
| PubMedID- 22383696 | Cardiovascular disease in children with chronic kidney disease. |
| PubMedID- 25093403 | Low-dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 22516527 | Association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the chronic renal insufficiency cohort [cric] study). |
| PubMedID- 21415179 | Appropriate use of these techniques can allow diagnosis of vascular diseases in patients with chronic kidney disease without using contrast materials. |
| PubMedID- 22660924 | Approach to cardiovascular disease prevention in patients with chronic kidney disease. |
| PubMedID- 19812502 | The presence of chronic kidney disease was associated with total cardiovascular diseases, independently of frs (odds ratio 1.64, 95% confidence interval 1.33-2.02, p < 0.001), score (odds ratio 1.55, 95% confidence interval 1.21-1.98, p < 0.001) and progetto cuore rs (odds ratio 1.59, 95% confidence interval 1.22-2.07, p < 0.001). |
| PubMedID- 20884696 | As stroke is a leading cause of mortality and morbidity worldwide, and several strategies, such as blood pressure control and use of statins and aspirin, may reduce subsequent cardiovascular disease in patients with chronic kidney disease, it is important to identify people at potential high risk, then appropriate therapy can be applied.7 8 we carried out a systematic review and meta-analysis to determine whether a link exists between reduced egfr and incident stroke and the magnitude of any relation. |
| PubMedID- 23419899 | Management of cardiovascular disease in patients with kidney disease. |
| PubMedID- 22244796 | Background: accelerated vascular calcification contributes to cardiovascular disease burden in patients with chronic kidney disease (ckd). |
| PubMedID- 26500541 | The patient was known to have longstanding hypertension with stage 2 chronic kidney disease due to hypertensive/vascular disease. |
| PubMedID- 21387687 | [interventional revascularization for cardiovascular disease in patients with chronic kidney disease]. |
| PubMedID- 23470818 | Purpose of review: this review will examine advances in our understanding of the association between high-density lipoprotein (hdl) function and cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 24137013 | It was discovered during the search to identify proteins secreted by the kidney that could help explain the high incidence of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 22160646 | Purpose: advanced glycation end products (age), biomarkers of metabolic stress, are frequently encountered in chronic kidney disease (ckd) patients with cardiovascular disease. |
| PubMedID- 21556311 | Target diseases were knee and/or hip osteoarthritis, poliomyelitis, chronic kidney disease, discomforts of pregnancy, cardiovascular diseases, and rotator cuff tears. |
| PubMedID- 21625102 | Cardiovascular disease is increased in patients with chronic kidney disease (ckd) and is the principle cause of morbidity and mortality in these patients. |
| PubMedID- 26215643 | Serum phosphorus level is a risk factor for cardiovascular disease in patients with chronic kidney disease (ckd) [1–3]. |
| PubMedID- 23927055 | Cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 21342319 | A novel strategy in the management of cardiovascular disease in patients with end-stage kidney disease is the use of biochemical markers to facilitate the detection of cardiovascular abnormalities in the hope that this will allow effective therapy to be instituted earlier. |
| PubMedID- 23120811 | High incidence of cardiovascular diseases in patients with chronic kidney disease (ckd) can not soley be explained by traditional risk factors. |
| PubMedID- 25874808 | Discussion: given the high burden of cardiovascular disease in women with chronic kidney disease, this study will help guide clinical practice by summarizing current evidence on the use of hormone therapy for prevention of all-cause mortality, cardiovascular mortality, and cardiovascular morbidity in this population. |
| PubMedID- 21541471 | Assessment and management of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 26374599 | Insulin resistance (ir) is a novel cardiovascular risk factor that has been implicated in the pathogenesis of cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 24434383 | Knowledge of the epidemiology and risk profile of peripheral vascular disease among patients with chronic kidney disease (ckd) has a potential role for determining its outcome. |
| PubMedID- 21529268 | Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 25830914 | In this pilot study transcriptome analysis of peripheral blood monocytes was used to identify in an unprejudiced manner which factors could be discriminative for cardiovascular disease in patients with chronic kidney disease on hemodialysis. |
| PubMedID- 22410492 | Chronic microinflammation and its cellular hallmark, monocyte activation, contribute substantially to the tremendous burden of cardiovascular disease (cvd) in patients with chronic kidney diseases (ckd). |
| PubMedID- 21903983 | Background and objectives: autosomal dominant polycystic kidney disease (adpkd) is associated with a substantial cardiovascular disease burden including early onset hypertension, intracranial aneurysms, and left ventricular hypertrophy (lvh). |
| PubMedID- 20586902 | Screening for cardiovascular disease in patients with advanced chronic kidney disease. |
| PubMedID- 24018401 | Traditional risk factors do not account for increased cardiovascular disease in patients with chronic kidney disease (ckd), particularly individuals whose ckd has progressed to end-stage kidney disease requiring dialysis. |
| PubMedID- 22719023 | Aims: high calcium (ca), phosphate (p), and ca-p product (cpp) are associated with cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 21105458 | [obesity--the risk factor of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 22822101 | Aims: increased serum phosphorus levels are associated with cardiovascular disease in patients with chronic kidney disease (ckd) and in the general population. |